Insider Transactions in Q1 2023 at Mirum Pharmaceuticals, Inc. (MIRM)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 31
2023
|
Lara Longpre CHIEF DEVELOPMENT OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
9,625
+8.31%
|
-
|
|
Jan 31
2023
|
Christopher Peetz CHIEF EXECUTIVE OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+29.49%
|
-
|
|
Jan 31
2023
|
Peter Radovich PRESIDENT AND COO |
BUY
Grant, award, or other acquisition
|
Direct |
14,440
+27.47%
|
-
|
|
Jan 31
2023
|
Pamela Vig CHIEF SCIENTIFIC OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
9,625
+23.39%
|
-
|
|
Jan 09
2023
|
Pamela Vig CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
1,379
-4.81%
|
$27,580
$20.62 P/Share
|
|
Jan 09
2023
|
Peter Radovich PRESIDENT AND COO |
SELL
Open market or private sale
|
Direct |
1,379
-3.97%
|
$27,580
$20.62 P/Share
|
|
Jan 09
2023
|
Lara Longpre CHIEF DEVELOPMENT OFFICER |
SELL
Open market or private sale
|
Direct |
1,003
-0.95%
|
$20,060
$20.62 P/Share
|
|
Jan 09
2023
|
Christopher Peetz CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
5,159
-5.31%
|
$103,180
$20.62 P/Share
|